Pier Capital’s Standard BioTools LAB Stock Holding History

Pier Capital’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-254,135	Closed	-$7.47M	–	151
2014 Q2	$7.47M	Sell	254,135 -137,898	-35%	-$4.42M	1.06%	34
2014 Q1	$17.3M	Buy	392,033 +62,737	+19%	+$2.76M	2.22%	1
2013 Q4	$12.6M	Sell	329,296 -15,881	-5%	-$468K	1.68%	5
2013 Q3	$7.57M	Buy	+345,177	New	+$6.78M	1.07%	29

Other funds holding LAB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pier Capital's LAB Position: Q3 2014 in Review

Pier Capital sold out of Standard BioTools (LAB) in Q3 2014, closing a stake of 254,135 shares — an estimated $7.47M sold.

Pier Capital first reported a position in LAB in Q3 2013 and held it in 4 quarters. The position peaked at $17.3M in Q1 2014. 99 funds tracked by Wall St. Rank hold LAB as of Q3 2014.

Pier Capital reported no remaining Standard BioTools position as of Q3 2014 after selling out during the quarter.
Pier Capital sold 254,135 Standard BioTools shares in Q3 2014, an estimated $7.47M.
Pier Capital first reported a position in Standard BioTools in Q3 2013 and held it in 4 quarters.
Pier Capital's Standard BioTools position peaked at $17.3M in Q1 2014.
99 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2014.

Based on Pier Capital's 13F filing for Q3 2014, filed 14 Nov 2014.